Method‐of‐use study of naltrexone sustained release (SR)/bupropion SR on body weight in individuals with obesity

OBJECTIVE: This study assessed the effects of 32 mg naltrexone sustained release (SR)/360 mg bupropion SR (NB) on body weight in adults with obesity, with comprehensive lifestyle intervention (CLI), for 78 weeks. METHODS: In this phase 3b, randomized, open‐label, controlled study, subjects received...

Descripción completa

Detalles Bibliográficos
Autores principales: Halseth, Amy, Shan, Kevin, Walsh, Brandon, Gilder, Kye, Fujioka, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2016
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299461/
https://www.ncbi.nlm.nih.gov/pubmed/28026920
http://dx.doi.org/10.1002/oby.21726

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5299461/
https://www.ncbi.nlm.nih.gov/pubmed/28026920
http://dx.doi.org/10.1002/oby.21726

Ejemplares similares